SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $135.6 million in its first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.33.

The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.

The biopharmaceutical company posted revenue of $835,000 in the period, which also did not meet Street forecasts. Seven analysts surveyed by Zacks expected $1.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK